Imaging to evaluate treatment response in esophageal cancer
Part of Cancer, Digestive system clinical trials.
This trial uses CT and MRI scans before and after chemotherapy or radiation to see how well the treatment worked in esophageal cancer. The goal is to match scan results with what doctors find after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with esophageal cancer through a biopsy.
- You received chemotherapy, radiation, or immunotherapy before surgery.
- You had both a CT scan and an MRI before and after your treatment.
- Your medical records before and after surgery are complete.
- You have no other active cancer or past cancer treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new treatment approach for esophageal cancer that includes chemotherapy and immunotherapy before surgery. The goal is to see if this combination can help shrink the tumor and improve outcomes.
This trial uses advanced imaging tests (spectral CT, multimodal MRI, and FAPI PET-CT) before surgery to find if esophageal cancer has spread to lymph nodes. The goal is to improve how doctors predict and diagnose lymph node metastasis using these scans, along with pathology and AI analysis.
This study looks at whether detailed scans taken before treatment can predict how well chemo and immunotherapy will work for advanced esophageal cancer. The goal is to improve treatment planning and potentially reduce side effects by personalizing care.
This trial uses a combination of imaging and clinical data to see if a computer model can predict how well your treatment will work. It aims to help doctors better understand your cancer risk and choose the best treatment plan for you.
This trial is studying how MRI images can help predict response to a combination of chemotherapy and immunotherapy before surgery for head and neck cancer. It aims to improve treatment planning for patients with this type of cancer.
This trial is testing an AI system that uses MRI scans and tissue samples to help doctors choose the best treatment for esophageal cancer. It's only for people who haven't had any cancer treatment yet.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.